Market Research Logo

US Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020

US Cardiovascular Devices Market Opportunity and Growth Trend Forecast Till 2020


The Market Intelligence report provides critical market data for US cardiovascular devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.

It’s vital “cross category comparison” and “cross sub-category comparison” section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.

It covers important categories such as cardiac assist devices, cardiac catheters and guidewires, cardiac rhythm management, cardiovascular heart valve and repair, cardiovascular monitoring systems, cardiovascular surgery, interventional cardiovascular devices, and peripheral vascular devices.
Market Size
Market size in terms of value ($) and volume (units), for each level of segmentation from 2007 to 2014 and forecast till 2020.

Market Growth

Market growth in terms of value ($) and volume (units), for each level of segmentation from 2007 to 2014 and forecast till 2020.
Competitive Analysis
Market share (%) of companies is covered at sector and category level for 2014.

Pricing Analysis

Average selling price ($) for each product type from 2007 – 2014 and forecast till 2020.

Cross category comparison and cross sub-category comparison – Forecast and historic market growth and market size comparison for various categories and sub-categories from 2007 to 2014 and 2014 to 2020.

Recent Events and Developments

Cardiovascular Devices Market Segmentation
Cardiac Assist Devices
Total Artificial Heart
Ventricular Assist Devices (VAD)
Cardiac Catheters and Guidewires
Cardiac Catheter
Guiding Catheter
Angiography Catheter
Electrophysiology Diagnostic Catheter (EP Catheter- Diagnostic
Electrophysiology Catheter)
Electrophysiology Ablation Catheter
Intra-Aortic Balloon Catheters (IAB Catheters)
Guidewires
Coronary Guidewires
Peripheral Guidewires
Cardiac Rhythm Management
Pacemaker
Single Chamber Pacemaker (SCP)
Dual Chamber Pacemaker (DCP)
Cardiac Resynchronisation Therapy (CRT - P)
Implantable Cardioverter Defibrillator (ICD)
Single Chamber Defibrillator
Dual Chamber Defibrillator
Cardiac Resynchronisation Therapy (CRT - D)
Pacing and ICD Leads
Electrophysiology Lab Systems

Cardiovascular Heart Valve and Repair
Heart Valve
Mechanical Heart Valve (MHV)
Biological Heart Valve (Bioprosthetic Heart Valve (BHV)
Annuloplasty Rings

Cardiovascular Monitoring Systems
ECG Monitoring Equipment (Electrocardiogram)
ECG Stress Testing Systems
Holter Monitoring System
Event Monitoring Systems

Cardiovascular Surgery
Beating Heart Surgery Systems (BHS)
Cardiac Ablation Devices
Cardiopulmonary Bypass Equipment
Perfusion Disposables
Oxygenators
Custom Packs
Interventional Cardiovascular Devices
Coronary Stent
Bare Metal Stent (BMS)
Drug Eluting Stent (DES)
PTCA Balloon
Rx Balloon
Over the Wire Balloon (OTW Balloon /Over-The-Wire)
FW Balloon
Arteriotomy Closure Devices (ACDs)
Peripheral Vascular Devices
Peripheral Vascular Stent (PV Stent)
Inferior Vena Cava Filter
Embolic Protection Device
PTA Balloon
Grafts
Aortic Stent Graft
Synthetic Surgical Grafts


  • Market at a Glance
    • US Cardiovascular Devices
  • US Market for Cardiovascular Devices (2007-2020)
    • US Cardiovascular Devices Cross Category Analysis
      • Table US, Cardiovascular Devices Cross-Category Analysis, 2007-2020
    • US Cardiovascular Devices Revenue ($mn) by Category
      • Table US, Cardiovascular Devices, Revenue ($mn), 2007-2014
      • Table US, Cardiovascular Devices, Revenue ($mn), 2014-2020
    • US Cardiovascular Devices Company Shares, 2014
      • Table US, Cardiovascular Devices, Company Shares (%), 2014
  • US Market for Cardiac Rhythm Management (2007-2020)
    • Cardiac Rhythm Management Cross Sub-Category Analysis
      • Table US, Cardiac Rhythm Management, Cross Sub-Category Analysis, 2007-2020
    • Cardiac Rhythm Management Revenue ($mn) by Sub-Category
      • Table US, Cardiac Rhythm Management, Revenue ($mn), 2007-2014
      • Table US, Cardiac Rhythm Management, Revenue ($mn), 2014-2020
      • Implantable Cardioverter Defibrillator Revenue ($mn) by Segment
        • Table US, Implantable Cardioverter Defibrillator, Revenue ($mn), 2007-2014
        • Table US, Implantable Cardioverter Defibrillator, Revenue ($mn), 2014-2020
      • Pacemaker Revenue ($mn) by Segment
        • Table US, Pacemaker, Revenue ($mn), 2007-2014
        • Table US, Pacemaker, Revenue ($mn), 2014-2020
    • Cardiac Rhythm Management Volume (Units) by Sub-Category
      • Table US, Cardiac Rhythm Management, Volume (Units'000), 2007-2014
      • Table US, Cardiac Rhythm Management, Volume (Units'000), 2014-2020
      • Pacemaker Volume (Units) by Segment
        • Table US, Pacemaker, Volume (Units'000), 2007-2014
        • Table US, Pacemaker, Volume (Units'000), 2014-2020
      • Implantable Cardioverter Defibrillator Volume (Units) by Segment
        • Table US, Implantable Cardioverter Defibrillator, Volume (Units'000), 2007-2014
        • Table US, Implantable Cardioverter Defibrillator, Volume (Units'000), 2014-2020
    • Cardiac Rhythm Management Average Prices ($)
      • Table US, Cardiac Rhythm Management, Average Prices ($ '000), 2007-2014
      • Table US, Cardiac Rhythm Management, Average Prices ($ '000), 2014-2020
    • US Cardiac Rhythm Management Company Shares, 2014
      • Table US, Cardiac Rhythm Management, Company Shares (%), 2014
  • US Market for Interventional Cardiology (2007-2020)
    • Interventional Cardiology Cross Sub-Category Analysis
      • Table US, Interventional Cardiology, Cross Sub-Category Analysis, 2007-2020
    • Interventional Cardiology Revenue ($mn) by Sub-Category
      • Table US, Interventional Cardiology, Revenue ($mn), 2007-2014
      • Table US, Interventional Cardiology, Revenue ($mn), 2014-2020
      • Coronary Stent Revenue ($mn) by Segment
        • Table US, Coronary Stent, Revenue ($mn), 2007-2014
        • Table US, Coronary Stent, Revenue ($mn), 2014-2020
      • PTCA Balloon Revenue ($mn) by Segment
        • Table US, PTCA Balloon, Revenue ($mn), 2007-2014
        • Table US, PTCA Balloon, Revenue ($mn), 2014-2020
    • Interventional Cardiology Volume (Units) by Sub-Category
      • Table US, Interventional Cardiology, Volume (Units'000), 2007-2014
      • Table US, Interventional Cardiology, Volume (Units'000), 2014-2020
      • Coronary Stent Volume (Units) by Segment
        • Table US, Coronary Stent, Volume (Units'000), 2007-2014
        • Table US, Coronary Stent, Volume (Units'000), 2014-2020
      • PTCA Balloon Volume (Units) by Segment
        • Table US, PTCA Balloon, Volume (Units'000), 2007-2014
        • Table US, PTCA Balloon, Volume (Units'000), 2014-2020
    • Interventional Cardiology Average Prices ($)
      • Table US, Interventional Cardiology, Average Prices ($), 2007-2014
      • Table US, Interventional Cardiology, Average Prices ($), 2014-2020
    • US Interventional Cardiology Company Shares, 2014
      • Table US, Interventional Cardiology, Company Shares (%), 2014
  • US Market for Heart Valve and Repair (2007-2020)
    • Heart Valve and Repair Cross Sub-Category Analysis
      • Table US, Heart Valve and Repair, Cross Sub-Category Analysis, 2007-2020
    • Heart Valve and Repair Revenue ($mn) by Sub-Category
      • Table US, Heart Valve and Repair, Revenue ($mn), 2007-2014
      • Table US, Heart Valve and Repair, Revenue ($mn), 2014-2020
      • Heart Valve Revenue ($mn) by Segment
        • Table US, Heart Valve, Revenue ($mn), 2007-2014
        • Table US, Heart Valve, Revenue ($mn), 2014-2020
    • Heart Valve and Repair Volume (Units) by Sub-Category
      • Table US, Heart Valve and Repair, Volume (Units'000), 2007-2014
      • Table US, Heart Valve and Repair, Volume (Units'000), 2014-2020
      • Heart Valve Volume (Units) by Segment
        • Table US, Heart Valve, Volume (Units'000), 2007-2014
        • Table US, Heart Valve, Volume (Units'000), 2014-2020
    • Heart Valve and Repair Average Prices ($)
      • Table US, Heart Valve and Repair, Average Prices ($), 2007-2014
      • Table US, Heart Valve and Repair, Average Prices ($), 2014-2020
    • US Heart Valve and Repair Company Shares, 2014
      • Table US, Heart Valve and Repair, Company Shares (%), 2014
  • US Market for Cardiac Catheters and Guidewires (2007-2020)
    • Cardiac Catheters and Guidewires Cross Sub-Category Analysis
      • Table US, Cardiac Catheters and Guidewires, Cross Sub-Category Analysis, 2007-2020
    • Cardiac Catheters and Guidewires Revenue ($mn) by Sub-Category
      • Table US, Cardiac Catheters and Guidewires, Revenue ($mn), 2007-2014
      • Table US, Cardiac Catheters and Guidewires, Revenue ($mn), 2014-2020
      • Cardiac Catheters Revenue ($mn) by Segment
        • Table US, Cardiac Catheters, Revenue ($mn), 2007-2014
        • Table US, Cardiac Catheters, Revenue ($mn), 2014-2020
      • Guidewires Revenue ($mn) by Segment
        • Table US, Guidewires, Revenue ($mn), 2007-2014
        • Table US, Guidewires, Revenue ($mn), 2014-2020
    • Cardiac Catheters and Guidewires Volume (Units) by Sub-Category
      • Table US, Cardiac Catheters and Guidewires, Volume (Units'000), 2007-2014
      • Table US, Cardiac Catheters and Guidewires, Volume (Units'000), 2014-2020
      • Cardiac Catheters Volume (Units) by Segment
        • Table US, Cardiac Catheters, Volume (Units'000), 2007-2014
        • Table US, Cardiac Catheters, Volume (Units'000), 2014-2020
      • Guidewires Volume (Units) by Segment
        • Table US, Guidewires, Volume (Units'000), 2007-2014
        • Table US, Guidewires, Volume (Units'000), 2014-2020
    • Cardiac Catheters and Guidewires Average Prices ($)
      • Table US, Cardiac Catheters and Guidewires, Average Prices ($), 2007-2014
      • Table US, Cardiac Catheters and Guidewires, Average Prices ($), 2014-2020
    • US Cardiac Catheters and Guidewires Company Shares, 2014
      • Table US, Cardiac Catheters and Guidewires, Company Shares (%), 2014
  • US Market for Peripheral Vascular Devices (2007-2020)
    • Peripheral Vascular Devices Cross Sub-Category Analysis
      • Table US, Peripheral Vascular Devices, Cross Sub-Category Analysis, 2007-2020
    • Peripheral Vascular Devices Revenue ($mn) by Sub-Category
      • Table US, Peripheral Vascular Devices, Revenue ($mn), 2007-2014
      • Table US, Peripheral Vascular Devices, Revenue ($mn), 2014-2020
      • Grafts Revenue ($mn) by Segment
        • Table US, Grafts, Revenue ($mn), 2007-2014
        • Table US, Grafts, Revenue ($mn), 2014-2020
    • Peripheral Vascular Devices Volume (Units) by Sub-Category
      • Table US, Peripheral Vascular Devices, Volume (Units'000), 2007-2014
      • Table US, Peripheral Vascular Devices, Volume (Units'000), 2014-2020
      • Grafts Volume (Units) by Segment
        • Table US, Grafts, Volume (Units'000), 2007-2014
        • Table US, Grafts, Volume (Units'000), 2014-2020
    • Peripheral Vascular Devices Average Prices ($)
      • Table US, Peripheral Vascular Devices, Average Prices ($), 2007-2014
      • Table US, Peripheral Vascular Devices, Average Prices ($), 2014-2020
    • US Peripheral Vascular Devices Company Shares, 2014
      • Table US, Peripheral Vascular Devices, Company Shares (%), 2014
  • US Market for Cardiovascular Surgery (2007-2020)
    • Cardiovascular Surgery Cross Sub-Category Analysis
      • Table US, Cardiovascular Surgery, Cross Sub-Category Analysis, 2007-2020
    • Cardiovascular Surgery Revenue ($mn) by Sub-Category
      • Table US, Cardiovascular Surgery, Revenue ($mn), 2007-2014
      • Table US, Cardiovascular Surgery, Revenue ($mn), 2014-2020
      • Perfusion Disposables Revenue ($mn) by Segment
        • Table US, Perfusion Disposables, Revenue ($mn), 2007-2014
        • Table US, Perfusion Disposables, Revenue ($mn), 2014-2020
    • Cardiovascular Surgery Volume (Units) by Sub-Category
      • Table US, Cardiovascular Surgery, Volume (Units'000), 2007-2014
      • Table US, Cardiovascular Surgery, Volume (Units'000), 2014-2020
      • Perfusion Disposables Volume (Units) by Segment
        • Table US, Perfusion Disposables, Volume (Units'000), 2007-2014
        • Table US, Perfusion Disposables, Volume (Units'000), 2014-2020
    • Cardiovascular Surgery Average Prices ($)
      • Table US, Cardiovascular Surgery, Average Prices ($ '000), 2007-2014
      • Table US, Cardiovascular Surgery, Average Prices ($ '000), 2014-2020
    • US Cardiovascular Surgery Company Shares, 2014
      • Table US, Cardiovascular Surgery, Company Shares (%), 2014
  • US Market for Cardiovascular Monitoring Systems (2007-2020)
    • Cardiovascular Monitoring Systems Cross Sub-Category Analysis
      • Table US, Cardiovascular Monitoring Systems, Cross Sub-Category Analysis, 2007-2020
    • Cardiovascular Monitoring Systems Revenue ($mn) by Sub-Category
      • Table US, Cardiovascular Monitoring Systems, Revenue ($mn), 2007-2014
      • Table US, Cardiovascular Monitoring Systems, Revenue ($mn), 2014-2020
    • Cardiovascular Monitoring Systems Volume (Units) by Sub-Category
      • Table US, Cardiovascular Monitoring Systems, Volume (Units), 2007-2014
      • Table US, Cardiovascular Monitoring Systems, Volume (Units), 2014-2020
    • Cardiovascular Monitoring Systems Average Prices ($)
      • Table US, Cardiovascular Monitoring Systems, Average Prices ($), 2007-2014
      • Table US, Cardiovascular Monitoring Systems, Average Prices ($), 2014-2020
    • US Cardiovascular Monitoring Systems Company Shares, 2014
      • Table US, Cardiovascular Monitoring Systems, Company Shares (%), 2014
  • US Market for Cardiac Assist Devices (2007-2020)
    • Cardiac Assist Devices Cross Sub-Category Analysis
      • Table US, Cardiac Assist Devices, Cross Sub-Category Analysis, 2007-2020
    • Cardiac Assist Devices Revenue ($mn) by Sub-Category
      • Table US, Cardiac Assist Devices, Revenue ($mn), 2007-2014
      • Table US, Cardiac Assist Devices, Revenue ($mn), 2014-2020
    • Cardiac Assist Devices Volume (Units) by Sub-Category
      • Table US, Cardiac Assist Devices, Volume (Units), 2007-2014
      • Table US, Cardiac Assist Devices, Volume (Units), 2014-2020
    • Cardiac Assist Devices Average Prices ($)
      • Table US, Cardiac Assist Devices, Average Prices ($ '000), 2007-2014
      • Table US, Cardiac Assist Devices, Average Prices ($ '000), 2014-2020
    • US Cardiac Assist Devices Company Shares, 2014
      • Table US, Cardiac Assist Devices, Company Shares (%), 2014
  • Recent Global Developments
    • Products
      • Sorin Group Announced First World Implant of Crown PRT Heart Valve
      • Boston Scientific launched Promus PREMIER Everolimus-Eluting Platinum Chromium coronary stent system in Japan
      • Boston Scientific began expansion of the S-ICD system in Asia
      • Edwards Lifesciences announced first human implants with mitral transcatheter valve system
      • Medtronic announced first U.S. implant of world's smallest, minimally invasive cardiac pacemaker
      • Federal Jury found Medtronic CoreValve Willfully infringes Edwards' Transcatheter Valve Patent
      • SynCardia hit record-setting 150th implant of the total artificial heart in 2013
      • Sorin Group launched INTENSIA family of ICD and CRT-D Devices Featuring DF-4 high voltage connector
      • Endurant II AAA stent graft from Medtronic delivers durable, consistent and proven outcomes in real-world setting
      • Boston Scientific announced first commercial implants of the Lotus Valve System in Europe
      • FDA classified Medtronic's worldwide voluntary field action on guidewires as class I recall
      • Medtronic to resume sales of CoreValve System in Germany
      • Edwards commented on German appellate court ruling
      • Sorin Group announce first European implant of Mitroflow Valsalva Conduit
      • FDA advisory panel recommend expanded indication for Medtronic CRT devices in patients with AV block and reduced heart function
      • Implantation of Boston Scientific COGNIS cardiac resynchronization therapy defibrillator (CRT-D) began in China
      • Boston Scientific launched Guidezilla Guide Extension Catheter in U.S. and Europe
      • St. Jude Medical launched wireless MRI-conditional pacemaker in Japan
      • First implant of Boston Scientific VITALIOTM pacemaker takes place in Europe
      • Medtronic launched lower-extremity indication for complete `se' vascular stent internationally
      • Medtronic announced launch of FlexCath advance steerable sheath, enhancing the arctic front advance cryoballoon system
      • Covidien announced launch of therapeutic device for treatment of resistant hypertension
      • Sorin Group announced first PARADYM RF implant and subsequent first SMARTVIEW remote monitoring activated patient in North America
      • First 34 U.S. patients implanted with smallest Triple Chamber CRT Device on the market-BIOTRONIK's New Evia HF-T Pacemaker
      • Medtronic's Endurant AAA stent graft delivered durable outcomes for abdominal aortic aneursym repair
      • BIOTRONIK launched the 3Flow Aspiration Catheter for improved thrombus aspiration
      • Philips to provide defibrillators on KLM and Air France's passenger flights
      • Sorin Group announced U.S. launch of new heart device for simultaneous implantation of an aortic tissue valve and ascending aorta
      • Early discontinuation of dual antiplatelet therapy after implant of Resolute DES does not lead to an increase in thrombosis rates
      • Medtronic stent successfully treated long lesions and small vessels, two characteristics typical of patients with diabetes, in multiple studies
      • BIOTRONIK launched implantable BioMonitor - highest precision in monitoring arrhythmias
      • Boston Scientific launched Victory Guidewire for crossing resistant lesions in peripheral arteries
      • St. Jude Medical announced launch of its MediGuide Technology
      • Medtronic launched new angioplasty catheter for Below-the-Knee arteries
      • Abbott launched Absorb Bioresorbable Vascular Scaffold internationally
      • BIOTRONIK presented world's first ProMRI portfolio and home monitoring technology at HRC 2012
      • Covidien expanded device portfolio for endovascular treatment of peripheral vascular disease
      • Philips TraceMasterVue and IntelliSpace ECG management systems now available to work in conjunction with mVisum, Inc.'s STEMI Alert smartphone app
      • BIOTRONIK launched Pulsar-35 Self-Expanding Stent and Passeo-14 PTA Balloon Catheter
      • Medtronic launched Resolute Integrity coronary stent system in Japan
      • BIOTRONIK demonstrated its commitment to heart failure solutions with world's first MR approved CRT Devices at ESC Congress 2012
      • First U.S. patient implanted with BIOTRONIK Lumax 740 Defibrillator Equipped with SMART detection to avoid unnecessary shocks
      • St. Jude Medical announced Japanese launch of industry's first small quadripolar technology to treat heart failure
      • Philips announced CX50 xMATRIX, the world's first portable echocardiography system to offer Real Time 3D Transesophageal Echo (Live 3D TEE)
      • MicroMed cardiovascular's HeartAssist 5 goes wireless
      • Sorin Group and Orange Business Services launched a remote monitoring solution for patients with implanted cardiac devices in Europe
      • BIOTRONIK presented world's broadest portfolio of cardiac devices approved for MR Scans at Cardiostim 2012
      • SynCardia total artificial heart replaced left ventricular assist devices in 7 patients
      • Numerex innovated remote monitoring of MicroMed Cardiovascular's heart pump technology
      • MAQUET Cardiovascular received CE mark for its new mega intra-aortic balloon catheter sizes
      • BIOTRONIK added new Reocor External Pacemaker to Its external product portfolio
      • Medtronic launched Endurant II AAA stent graft system in U.S
      • First Implantation of BIOTRONIK Lumax 740 ProMRI ICD in Asia
      • BIOTRONIK Evia HF-T, world's first MRI-approved CRT Pacemaker
      • New BIOTRONIK ICD and CRT-D Series gave patients first-ever access to MR scans, BIOTRONIK launched the Lumax 740 series with ProMRI
      • Increased reimbursement of self-expanding DES in Germany now for all indications
      • Medtronic expanded availability of Valiant Captivia stent graft in major global markets
      • Boston Scientific announced first implant and market launch of PROMUS Element Plus Stent System in Europe
      • Medtronic Endurant II AAA stent graft system launched internationally with CE Mark
    • Approvals
      • St. Jude Medical received CE Mark Approval for world's only multipoint pacing pacemaker
      • St. Jude Medical received approval from FDA for TactiCath Quartz contact force ablation catheter for treatment of Atrial Fibrillation
      • St. Jude Medical received CE Mark approval for pacing lead labeling expanding patient access to MRI Scans
      • Medtronic announced CE Mark for Recapturable CoreValve Evolut R System
      • Sorin Group announced FDA approval of Solo Smart
      • Sorin Group received European CE Mark Approval For Crown PRT Heart Valve
      • Medtronic CoreValve System Receives FDA Approval for Patients at High Risk for Surgery
      • Medtronic announced CE mark and launch of NC Euphora coronary balloon
      • Sorin Group received US FDA approval for the mitroflow aortic heart valve
      • Boston Scientific announced FDA approval of innovative new defibrillators and heart failure devices
      • Medtronic CRT devices now approved to treat patients with AV block and reduced heart function
      • Medtronic announced CE mark and European launch of first implantable cardioverter-defibrillator system to allow for full-body MRI scans
      • Abiomed received CE Mark for Impella RP
      • EDWARDS INTUITY Elite valve system received CE mark
      • Abbott announced FDA approval of its SUPERA stent to treat people with peripheral artery disease
      • Terumo received CE mark for its new drug-eluting stent, Ultimaster
      • Edwards' SAPIEN XT valve approved in Europe for transcatheter mitral and aortic valvein-valve procedures
      • Edwards received European approval for advanced SAPIEN 3 Valve
      • St. Jude Medical gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
      • Medtronic announced CE Mark and TGA Listing for the Symplicity Spyral MULTIELECTRODE CATHETER and Symplicity G3 Generator
      • MicroPort received CE approval for FireMagic, EasyFinder, EasyLoop and FireMagic 3D
      • Sorin Group announced CE Mark approval and first implant of KORA 100, a new MRI compatible pacing system
      • Endurant II AAA stent graft from Medtronic delivers durable, consistent and proven outcomes in real-world setting
      • Boston Scientific received FDA approval for Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System
      • Sorin Group announced CE Mark approval for the XL Version of the Perceval sutureless aortic valve
      • Sorin Group announced CE Mark approval and first implant of the new Solo Smart biological aortic pericardial heart valve
      • Boston Scientific received FDA clearance and CE Mark approval for Direxion Torqueable Microcatheter
      • FDA approved Medtronic-Proprietary Software for use with non-Medtronic leads to detect defibrillator lead issues
      • Boston Scientific received CE Mark for Lotus Valve System
      • Boston Scientific received FDA approval for IntellaTip MiFi XP ablation catheter and 510(k) clearance of Zurpaz 8.5F steerable sheath
      • Edwards received reimbursement approval for Sapien XT Valve in Japan
      • St. Jude Medical announced approval and first use of MediGuide enabled ablation catheters
      • St. Jude Medical launched wireless MRI-conditional pacemaker in Japan
      • Edwards Lifesciences received approval for SAPIEN XT in Japan
      • Cordis announced additional sizes of SLEEK OTW Platform
      • St. Jude Medical received CE Mark approval of MultiPoint pacing CRT-D
      • Sorin Group launched REPLY 200 family of pacemakers with sleep apnea monitoring for better management of cardiovascular co-morbidities
      • St. Jude Medical announced FDA approval of high-voltage devices with new safety features
      • Medtronic net FDA clearance and 'CE' Mark for new peripheral angioplasty balloon
      • Medtronic Garners first-of-its-kind FDA approval for 'AUI' device with Endurant II AAA Stent Graft System
      • Medtronic CoreValve System gain first approval for transcatheter valve-in-valve procedures
      • Sorin Group announced FDA approval and U.S. launch of SMARTVIEW remote monitoring solution for patients with implanted cardiac defibrillators
      • FDA approved longer lengths of Medtronic's Resolute Integrity stent
      • Sorin Group received conditional FDA approval to conduct respond CRT clinical trial using innovative heart failure management technology
      • InspireMD received CE mark approval for carotid embolic protection stent
      • Medtronic approved to update Resolute Integrity stent's `CE' Mark labeling on dual antiplatelet therapy
      • Promus PREMIER Everolimus-Eluting Platinum Chromium stent system received CE Mark approval
      • Medtronic announced CE Mark of Evera portfolio of implantable cardioverterdefibrillators
      • Biosensors receives CE Mark approval for BioFreedom
      • Covidien received CE Mark approval for EverFlex self-expanding peripheral stent with entrust delivery system
      • St. Jude Medical received CE Mark of next-generation cardiac device for stroke prevention
      • St. Jude Medical announced CE Mark approval of ViewFlex Xtra ICE catheter
      • St. Jude Medical announced FDA approval of new version of remote patient monitoring system
      • Medtronic announced launch of FlexCath Advance Steerable Sheath, enhancing the arctic front advance cryoballoon system
      • Abbott announced FDA approval and U.S. launch of next-generation XIENCE Xpedition drug eluting stent system
      • Sorin Group received PMDA approval and announced commercial launch of the Mitroflow Aortic Pericardial Heart Valve in Japan
      • St. Jude Medical announced CE Mark Approval of Assura family of implantable defibrillators including new quadripolar device
      • Edwards Lifesciences received approval for PERIMOUNT mitral heart valve in China
      • Boston Scientific Defibrillators received CE Mark for extended longevity
      • St. Jude Medical announced European approval of the portico transcatheter aortic heart valve
      • FDA approved Medtronic stent graft for aortic transection repair
      • Abiomed received FDA IDE Approval for use of new Impella RP in pivotal clinical study
      • Boston Scientific received CE mark approval for the SYNERGY everolimus-eluting platinum chromium coronary stent system, featuring a novel bioabsorbable polymer coating
      • Tryton presented positive data from more than 900 patients at TCT 2012 conference in Miami
      • Medtronic gained FDA clearance for new pediatric oxygenation system for neonate, infant and pediatric cardiopulmonary bypass surgery
      • PROMUS labele to include three-month dual anti-platelet therapy
      • Mustang coronary stent system reregistered successfully by SFDA
      • FDA approved expanded indication for Edwards Lifesciences' transcatheter valve
      • Boston Scientific received FDA approval of first-in-class S-ICD system for patients at risk of sudden cardiac arrest
      • Medtronic gained CE Mark for CoreValve Evolut 23mm
      • Medtronic gained CE Mark for new oxygenation system for adult cardiac surgery
      • Sorin Group announced CE mark approval of extended indications and 2nd generation accessories for Perceval S
      • Sorin Group received SFDA approval and announced commercial launch of REPLY and ESPRIT families of pacemakers in CHINA
      • Abiomed received FDA 510(k) clearance for new, higher flow Impella percutaneous heart pump, with peak flows of 4l/min
      • Elixir Medical received CE mark approval for DESyne BD Novolimus eluting coronary stent system with biodegradable polymer coating
      • Boston Scientific WATCHMAN left atrial appendage closure device received CE Mark approval for expanded use
      • Abbott received CE Mark and European Launch of Next-Generation XIENCE Xpedition Drug Eluting Stent
      • Medtronic announced CE Mark of Viva/Brava cardiac resynchronization therapy devices
      • Abbott's Omnilink Elite vascular balloon-expandable stent system received FDA approval for treatment of iliac artery disease
      • Boston Scientific INGENIO family of pacemakers received CE Mark approval for use in MRI scans
      • Abiomed received Health Canada Approval for Impella CVAD
      • ENDOSENSE and BIOTRONIK announced CE mark approval, first clinical use of the new TactiCath Quartz Force-Sensing Ablation Catheter
      • Rontis got CE mark approval for Abrax
      • St. Jude Medical announced FDA clearance of the AMPLATZER Vascular Plug 4
      • Tryton announced positive clinical data from more than 900 patients treated with its bifurcation stent system at Euro PCR 2012
      • Abbott's XIENCE (PRIME and V DES) received CE mark for minimum three-month duration of dual anti-platelet therapy
      • Medtronic receives European regulatory approval for new indications for its Resolute Integrity in Europe
      • FDA approved BIOTRONIK Next Generation ICDs and CRT-Ds
      • FDA approved Medinol's PioNIR Plus stent
      • Abiomed received CE Mark for Impella CVAD
      • Medtronic received FDA Approval to treat mildly symptomatic heart failure patients through expanded indication for CRT-D
      • Abbott received approval for next-generation XIENCE PRIME DES in Japan
      • St. Jude Medical received FDA approval for PressureWire Fractional Flow Reserve
      • Covidien peripheral vascular stent system received FDA approval
      • Abbott's Absolute Pro Vascular Self-Expanding Stent System received FDA approval for treatment of iliac artery disease
      • Medtronic received CE Mark for pacemaker lead that will expand patient access to MRI technology
      • Boston Scientific launched PROMUS Element Platinum Chromium stent system in Japan
      • Boston Scientific received industry's first FDA approval for Drug-Eluting coronary stent use in heart attack patients
      • Medtronic Resolute Integrity DES received FDA approval for treating coronary artery disease
      • Edwards Intuity valve system received CE Mark
      • Medtronic announced FDA approval of DF4 high-voltage connector system for implantable cardioverter defibrillator and cardiac resynchronization therapy devices
    • Clinical Trials
      • Boston Scientific initiated study of Promus PREMIER coronary stent system in underserved patient populations
      • Boston Scientific enrolled first patients in U.S. trial of the Lotus Valve System
      • REPRISE II data demonstrated sustained safety and performance outcomes at one year for the Boston Scientific Lotus Valve System
      • Absorb II study shows Abbott's dissolving heart device comparable to the world's leading heart stent
      • Core Valve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients
      • CoreValve Data Demonstrate Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients
      • Transcatheter Valve Durability Sustained Through Five Years
      • Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R
      • Initial patient enrolled in BioFreedom USA: first major American trial for biosensors
      • Medtronic CoreValve System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study
      • St. Jude Medical announced two year data from FAME 2 Trial
      • Late-Breaking clinical trial results show medtronic-exclusive pacemaker algorithm significantly delays atrial fibrillation
      • Boston Scientific begins clinical trial of ACUITY X4 LV Pacing Leads and RELIANCE 4-FRONT ICD leads
      • Medtronic announced first human implant of world's smallest, minimally invasive cardiac pacemaker
      • In trial of rivals, Medtronic's Resolute Integrity Stent outperforms Promus Element Stent on longitudinal strength
      • Medtronic CoreValve U.S. pivotal trial affirms benefits of self-expanding transcatheter aortic valve replacement in patients treated via alternative access routes
      • REVA announced first clinical results from ReZolve2 trial
      • Medtronic initiated clinical study of Recapturable CoreValve Evolut R
      • Late breaking clinical trial reveals reduced risk of atrial fibrillation for patients with Medtronic devices featuring AdaptivCRT
      • Diabetic patients at high risk for aortic valve surgery experienced lower all-cause mortality when treated with SAPIEN Valve
      • HeartWare received FDA approval to enroll supplemental patient cohort in destination therapy trial
      • Edwards received IDE for US clinical trial of SAPIEN 3 Transcatheter Valve
      • Reva expands CE Mark trial to Australia and New Zealand
      • Sorin Group announced results of the DREAM clinical study
      • Sorin Group announced first U.S. implant of Paradym RF SonR CRT-D FOR respond CRT IDE clinical trial
      • Endurant AAA Stent Graft delivered durable outcomes for abdominal aortic aneurysm repair
      • Medtronic's In.Pact Falcon Drug-Eluting Balloon yielded positive outcomes in small coronary arteries
      • For bifurcation lesions in coronary arteries, Medtronic's Resolute Stent delivers strong long-term results
      • Reva Medical announced ReZolve2 clinical trial initiation
      • PLATINUM China trial demonstrated positive outcomes for the Boston Scientific PROMUS Element stent
      • With Medtronic Resolute stent, interrupting dual antiplatelet therapy after one month shows no increased safety risk in robust analysis
      • New data reinforce strong long-term clinical performance of Abbott's Absorb bioresorbable vascular scaffold
      • Abbott's Minimally Invasive MitraClip System for mitral regurgitation demonstrated positive clinical and quality- of-life results for patients too high risk for surgery
      • The Boston Scientific PROMUS Element Platinum Chromium stent demonstrated continued low event rates through three years
      • STENTYS Self-Apposing stent demonstrated lowest mortality rate among large heart attack trials
      • Abbott initiated clinical trial of Absorb in the United States
      • Covidien completed patient enrollment in Iliac Stent Clinical Study Series
      • St. Jude Medical announced first implant evaluating new size of portico heart valve in ongoing European clinical trial
      • Two-year clinical study supports safety and efficacy of Covidien Solitaire FR revascularization device
      • Medtronic Drug-Eluting balloon study completed enrollment
      • New clinical trial used continuous cardiac monitoring to evaluate atrial fibrillation in high-risk patients
      • Covidien completed enrollment in the DEFINITIVE AR study
      • Covidien opened patient enrollment for SWIFT PRIME acute ischemic stroke study
      • New clinical trial first to evaluated effectiveness of CRT-P in symptomatic heart failure patients with mild-to-moderate structural heart disease
      • First patient treated in the Boston Scientific ZERO AF clinical trial to evaluate the safety and performance of the blazer open-irrigated temperature ablation catheter
      • St. Jude medical enrolled first patient in ilumien I study to develop guidance for stent optimization
      • BIOTRONIK announced first U.S. implants of PRO-Kinetic Energy stent in BIOHELIX-I IDE clinical trial
      • Biosensors announced first patient enrolled in LEADERS FREE
      • First patient enrolled in the Boston Scientific multicenter study of the SYNERGY stent (bioabsorbable polymer)
      • St. Jude Medical announced first transapical implant of portico transcatheter aortic heart valve
      • First U.S. patient treated in Medtronic clinical trial evaluated corevalve system in intermediate-risk patients
      • BIOTRONIK Pulsar stent delivered excellent primary patency and freedom from TLR rates in 12-month 4EVER study results
      • BIOTRONIK announced first U.S. Pulsar-18 implant in BIOFLEX-I investigational device exemption (IDE) clinical trial
      • St. Jude Medical announced preliminary third-party validation of registry data for optiminsulated defibrillation leads
      • Improved device programming reduces inappropriate therapy and risk of death for implantable defibrillator patients
      • Positive results of InspireMD's MASTER Trial to be published on November 6 In Journal of American College of Cardiology
      • GOLDEN TIME study showed BIOTRONIK AlCath Gold Ablation Catheter create lesions 33% faster
      • BIOTRONIK announced positive results for Pantera Lux Paclitaxel releasing balloon in both diabetic and non diabetic subgroups
      • First results from Medtronic engager European pivotal trial demonstrate positive outcomes
      • Elixir Medical announced enrollment completion of the DESolve Nx pivotal trial for fully bioresorbable scaffold system
      • Elixir Medical Corporation announced three-year data from EXCELLA II for DESyne system
      • Early follow-up imaging assessment of ReZolve scaffold
      • Data from FAME II Trial Concluded FFR-Guided PCI is cost effective and improves patient outcomes
      • Abiomed announced clinical progress on Symphony program, including second successful implant in Canada
      • BioMatrix Flex improves clinical outcomes compared with Cypher Select for up to five years
      • Stentys received US FDA approval to initiate first US clinical trial with self-apposing stent
      • STENTYS self-apposing stent continued to demonstrate low mortality at one year in APPOSITION III trial
      • New study results show high survival rates and improved quality of life for patients with Medtronic corevalve system
      • First patient enrolled in REPRISE II TAVR clinical trial to evaluate the safety and performance of the Lotus valve system
      • The REWAC Registry (Real World Active Stent) showed 0% ST at two years follow up
      • Medtronic completed enrollment in landmark study of IN.PACT drug-eluting balloon in peripheral artery disease
      • Medtronic completed first-in-man study for investigational next-generation multielectrode renal denervation system in patients with treatment-resistant hypertension
      • New data reinforced positive clinical outcomes for direct aortic implants using the Medtronic corevalve system
      • Results of InspireMD's MASTER Stent trial scheduled for late breaking trials session at TCT in Miami, FL Oct. 24
      • Medtronic announced first patient enrollment in global heart rhythm study
      • First patient successfully treated with innovative procedure focused on most challenging atrial fibrillation patient segment
      • AtriCure launched three-year post-approval study for the surgical correction of atrial fibrillation
      • More effective risk-stratification for ICD interventions needed: BIOTRONIK PARCADIA study aims to address open clinical questions
      • New England journal of medicine published FAME II Trial Results revealed better patient outcomes with FFR-guided cardiac stenting
      • InspireMD announced positive results from MGuard Stent MASTER Trial for emergency treatment of heart attack patients
      • C.R. Bard announced enrollment completion of first ever IDE-approved drug-coated balloon clinical trial and initiation of large continuation registry study
      • First CRT-D patient enrolled in the EuroEco ICD/CRT-D trial assessing the economic effect of BIOTRONIK Home Monitoring
      • Medtronic begun global clinical trial evaluating corevalve system implantation in intermediate-risk patients
      • Initial clinical enrollment of ReZolve was completed: no MACE was reported
      • Large-scale BIOTRONIK SPIRIT-ICD study enrollment completed
      • EDWARDS INTUITY valve system cleared to begin U.S trial
      • Medtronic stent graft chosen by U.S. FDA for innovative program
      • A Milestone for MicroMed Cardiovascular
      • STENTYS startd clinical trial to broaden portfolio with new DES
      • FDA panel recommended approval of Edwards Transcatheter Valve for high-risk patients
      • Edwards received IDE for U.S. clinical trial of new heart valve tissue treatment platform
      • Three-Year "NOBORI 2" Post Marketing Study Results Confirm Long-term Safety and Efficacy of Terumo's Nobori Drug-Eluting Stent
      • InspireMD announced enrollment completion in MASTER Trial
      • Tryton announced positive clinical data from 900 patients treated with its bifurcation stent system at EuroPCR 2012
      • BIOTRONIK announced positive results for Pulsar Stent in 4EVER clinical study
      • BIOTRONIK announced positive results for Pantera Lux Paclitaxel Releasing Balloon in both diabetic and nondiabetic subgroups
      • BIOTRONIK announced positive results for the Passeo-18 Lux Peripheral Vascular Paclitaxel Releasing Balloon
      • REVA Medical announced interim clinical results at EuroPCR: no major adverse coronary events from RESTORE trial
      • PROMUS Element stent demonstrated excellent long-term safety and effectiveness in PLATINUM small vessel study
      • Axxess self-expanding bifurcation DES shown to be safe and effective up to four years
      • Early coronary artery healing advantage of OrbusNeich's combo stent compared with TAXUS shown in clinical trials
      • InspireMD announced positive 3-year results from extended MAGICAL Trial
      • Elixir Medical announces results from DESolve I for fully bioresorbable DE coronary scaffold system
      • STENTYS Self-Apposing stent demonstrated very low mortality at one month in 1,000 high risk heart attack patients
      • Study confirms BioMatrix reduced cardiac events in acute MI patients more effectively than a BMS
      • Twelve-month ENERGY registry results of PRO-Kinetic Energy passively coated stent presented at EuroPCR
      • EuroPCR announced large-scale study with BioFreedom
      • Edwards SAPIEN XT transcatheter valve continued to achieve positive patient outcomes in 94 center post-approval study
      • Edwards SAPIEN XT transcatheter valve continued to achieve positive patient outcomes in 94 center post-approval study
      • Twelve-month ENERGY registry results of PRO-Kinetic Energy passively coated stent presented at the European Conference of Paris Course on Revascularization (PCR)
      • Fame II trial demonstrated FFR-Guided PCI superior to medical treatment in preliminary findings
      • First ICD implantation performed on patient in Biotronik's ESCAPE-ICD registry in Latin America
      • St. Jude Medical announced results of SCD-HeFT 10-year follow-up study
      • Medicare to cover transcatheter heart valve procedure
      • St. Jude Medical updated optim lead registry data and status of Riata Leads study in Bi-Annual product performance report
      • OrbusNeich's Genous stent achieved complete endothelialization at two weeks
      • Igaki-Tamai biodegradable stent (Kyoto Medical Planning) safe for long-term treatment of CAD
      • Medtronic announced global drug-eluting balloon study
      • InspireMD announced continued progress in MASTER Trial
      • BIOTRONIK REPLACE study established new benchmarks for CIED replacement
      • Bifurcation stenting with OrbusNeich's Genous stent showed low rates of revascularization and ST at 12 months
      • RECORD study proved efficacy and safety of BIOTRONIK closed loop stimulation (CLS) pacemaker therapy
      • Medtronic sponsored study found pacemakers reduce fainting in patients
      • Two year data from PLATINUM Workhorse trial demonstrate superior efficacy of PROMUS Element over Xience V
      • Two randomized clinical trials identify no cases of longitudinal deformation with Boston Scientific PTCr stents
      • Medtronic Resolute DES delivers durable clinical outcomes through two years in major studies
      • OrbusNeich's Genous stent: a safe and effective option in patients with ST-segment elevation myocardial infarction
      • Update on REVA's RESTORE clinical trial
      • InspireMD announced positive clinical data from trial of MGuard
      • A prospective, randomized and multicentre trial comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS trial.
    • Deals
      • Medtronic completed acquisition of Covidien
      • Medtronic to acquire Covidien for $42.9 billion in cash and stock
      • Abbott completed acquisition of Topera, Inc.
      • Abiomed announced acquisition of ECP to broaden and strengthen existing intellectual property and product platform
      • Abiomed acquired exclusive license for Opsens' optical sensor technology miniature optical pressure sensors to be integrated into Impella Heart Pump Catheters
      • Medtronic acquired majority of the shares of Biostar Creating a new Medtronic-Medicall collaboration in Turkey
      • Terumo announced exclusive acquisition right agreement with French Bioresorbable Scaffold Company, "ART"
      • MicroPort Scientific Corporation and Sorin Group sign joint venture agreement for cardiac rhythm management business in China
      • AtriCure completed acquisition of Estech
      • Boston Scientific and The Medicines Company announces U.S. co-promotion agreement for Promus PREMIER Stent System
      • Shareholders representing 70% of outstanding shares in Pulsion have agreed to accept Getinges offer in intended acquisition of Pulsion Medical Systems
      • HeartWare International announced acquisition of CircuLite, Inc.
      • Boston Scientific completed acquisition of Bard electrophysiology
      • St. Jude Medical announced acquisition and CE Mark approval of world's first leadless pacemaker
      • Apollo Hospitals and Medtronic announced a collaboration to bring an affordable, portable hemodialysis system to India
      • St. Jude Medical acquired Endosense
      • Bard announced agreement to acquire Medafor, Inc.
      • Medtronic advances healthcare services and solutions strategy with acquisition of Cardiocom
      • Terumo entered strategic alliance for DuraHeart II with Thoratec
      • Thoratec acquired DuraHeart II ventricular assist system
      • Bard to divest electrophysiology business
      • Terumo expanded peripheral intervention business Terumo concludes co-development agreement for PTA balloon catheters with Kaneka Corporation
      • Terumo expands sales collaboration in Japan with Biosensors for Nobori DES and extends licensing agreement to sell the product overseas
      • Cordis acquired Flexible Stenting Solutions, Inc.
      • Sorin Group announced the acquisition of Alcard
      • Biosensors collaborated with Terumo to promote Nobori in Japan
      • Medtronic completed strategic investment in LifeTech Scientific Corporation
      • Covidien completed acquisition of CV Ingenuity
      • Terumo Announces Strategic Alliance with Chinese AngioCare in Renal Denervation Technology for Hypertension Treatment
      • Sorin Group invested in HighLife, a development-stage company focused on percutaneous mitral valve replacement
      • Boston Scientific to acquire Vessix Vascular, Inc.
      • Medtronic completed acquisition of China Kanghui Holdings
      • Bard acquired Neomend, Inc
      • Edwards Lifesciences acquired BMEYE
      • Boston Scientific to acquire Rhythmia Medical, Inc.
      • Biosensors extended licensing agreement with Terumo to sell BioMatrix Technology globally
      • Medtronic Foundation announced new Heartrescue project
      • Philips and Corindus announced distribution agreement to sell Corindus' robotic-assisted interventional cardiology system in the United States
      • Sorin Group announced the acquisition of California Medical Laboratories (CALMED)
      • Sorin Group invested in Cardiosolutions, a development-stage company focused on mitral valve technology
      • Covidien completed acquisition of Oridion Systems Ltd.
      • MAQUET Cardiovascular announced acquisition of the Avalon Elite Bi-caval Dual Lumen Catheter and complimentary vascular access kits from Avalon Laboratories
      • Covidien and GE Healthcare form five-year collaboration
      • Abbott and St. Jude Medical broadened alliance for cardiovascular products in US
      • Medtronic launched new minimally invasive cardiac surgery products through exclusive distribution agreement with Miami instruments
      • Abbott and St. Jude medical broaden alliance for cardiovascular products in the US
      • Abbott's STARLIMS Business acquired distribution partners to build international presence
  • Appendix
    • Research Methodology
    • Information Sources
    • Market Segmentation - Cardiovascular Devices
    • Definitions
      • Cardiovascular Devices
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report